Connect with us


Moderna Just Made the Pfizer Vaccine’s Biggest Weakness an Even Bigger One – Motley Fool

Both vaccines do an impressive job of providing protection against COVID-19. But Moderna’s is much easier to get from production facilities into patients’ arms.



Article feature image

Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) have been close rivals in the COVID-19 vaccine race ever since they announced the starts of their phase 3 vaccine trials — on the very same day back in July. But Pfizer edged ahead en route to the finish line. The big pharmaceutical company scored the first FDA emergency use authorization (EUA) for a coronavirus vaccine in December.
Still, Moderna wasn’t far behind — the smaller biotech company’s vaccine earned its EUA only seven days later.
Since then,…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Weather advisory issued for strong winds Friday; hard freeze conditions in northern Utah –
Article feature image
Washington Post fact-checker calls out Biden’s spin on disappointing jobs report – Fox News
Article feature image
What will Utah look like after the pandemic? Panel offers insight into the future –